Next Article in Journal
Identification of KIF11 As a Novel Target in Meningioma
Previous Article in Journal
18F-FDG-PET Can Predict Microvessel Density in Head and Neck Squamous Cell Carcinoma
Previous Article in Special Issue
Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2 Breast Cancer
Article Menu

Export Article

Open AccessArticle
Cancers 2019, 11(4), 544; https://doi.org/10.3390/cancers11040544

CHI3L1, NTRK2, 1p/19q and IDH Status Predicts Prognosis in Glioma

1
EA3842 CAPTuR, Faculty of Medicine, University of Limoges, 2 Rue du Docteur Marcland, 87025 Limoges, France
2
Department of Medical Oncology, Limoges University Hospital, 2 rue Martin Luther King, 87042 Limoges, France
3
Bioinformatics Team, BISCEM Platform, CBRS, University of Limoges, 2 rue du Docteur Marcland, 87025 Limoges, France
4
EA7500 PEREINE, University of Limoges, 123 av. Albert Thomas, 87060 Limoges, France
5
Department of Neurosurgery, Limoges University Hospital, 2 rue Martin Luther King, 87042 Limoges, France
6
Department of Neuropathology and INSERM U1051, Hospital Saint Eloi—Gui de Chauliac, 80 av. Augustin Fliche, 34090 Montpellier, France
7
Department of Pathology, Limoges University Hospital, 2 rue Martin Luther King, 87042 Limoges, France
8
Department of Immunology, Limoges University Hospital, 2 rue Martin Luther King, 87042 Limoges, France
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Received: 8 February 2019 / Revised: 30 March 2019 / Accepted: 12 April 2019 / Published: 15 April 2019
(This article belongs to the Collection Cancer Biomarkers)
  |  
PDF [4690 KB, uploaded 15 April 2019]
  |     |  

Abstract

The aim of this study was to identify relevant biomarkers for the prognosis of glioma considering current molecular changes such as IDH mutation and 1p19q deletion. Gene expression profiling was performed using the TaqMan Low Density Array and hierarchical clustering using 96 selected genes in 64 patients with newly diagnosed glioma. The expression dataset was validated on a large independent cohort from The Cancer Genome Atlas (TCGA) database. A differential expression panel of 26 genes discriminated two prognostic groups regardless of grade and molecular groups of tumors: Patients having a poor prognosis with a median overall survival (OS) of 23.0 ± 9.6 months (group A) and patients having a good prognosis with a median OS of 115.0 ± 6.6 months (group B) (p = 0.007). Hierarchical clustering of the glioma TCGA cohort supported the prognostic value of these 26 genes (p < 0.0001). Among these genes, CHI3L1 and NTRK2 were identified as factors that can be associated with IDH status and 1p/19q co-deletion to distinguish between prognostic groups of glioma from the TCGA cohort. Therefore, CHI3L1 associated with NTRK2 seemed to be able to provide new information on glioma prognosis. View Full-Text
Keywords: glioma; IDH status; CHI3L1; NTRK2; prognosis glioma; IDH status; CHI3L1; NTRK2; prognosis
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Deluche, E.; Bessette, B.; Durand, S.; Caire, F.; Rigau, V.; Robert, S.; Chaunavel, A.; Forestier, L.; Labrousse, F.; Jauberteau, M.-O.; Durand, K.; Lalloué, F. CHI3L1, NTRK2, 1p/19q and IDH Status Predicts Prognosis in Glioma. Cancers 2019, 11, 544.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top